The Metrix blog
Patient empathy as a field skill: Why rare disease reps need more than product training
A Specialist Representative sits across from a physician who has treated eleven patients with the indicated condition…
Metrix's top picks
Scaling without full confidence: The hidden cost of “Almost Ready” reps
Three months after approval, the Chief Commercial Officer wants an answer. Pull through is behind plan, the field team has been live for eight weeks, and every rep on the roster passed certification with a score above ninety. The training worked but the field performance is not hitting the mark. That is the conversation most…
Breaking silos in rare disease: How training drives cross-functional excellence
A field rep visits a treating specialist on a Tuesday….
The 5 training gaps we consistently find in market access field teams
A Field Reimbursement Manager sits across from a billing manager…
Why your FRM is still a trouble‑shooter, not a strategic partner, and what training has to do with it
Field Reimbursement Managers (FRMs) were never meant to be trouble-shooters….
Stay ahead of the game with regular updates
All results
What keeps NSM strategy alive once the field is back to work?
The ballroom is full. The strategy is clear. The energy is high. National Sales Meetings do exactly…
Why AI makes us more human in training
In life sciences, the most impactful learning experiences don’t just transfer knowledge; they create confidence, empathy, and…
Agility in action: How pharma teams can thrive through disruption
Change isn’t coming to pharma, it’s already here. Product lifecycles are shorter. Access challenges are steeper. Market disruptions, mergers and acquisitions,…
Why pharma training needs a new playbook for rare disease
The rare disease sector is no longer a niche. Nearly half of all new drug approvals in the U.S….
The experiential edge: Why learning by doing drives behavior change
If you’ve ever tried to learn to swim from a manual, you know it doesn’t work. You…
Storytelling with purpose: Using patient narratives to transform pharma training
In pharma, facts and data are everywhere. Clinical results, safety data, prescribing guidelines, these are essential, but…
Why intelligent personalization is the future of pharma L&D
In pharma, training has never been “one-size-fits-all.” Your sales rep in oncology needs a very different learning…
From learning to business impact: Closing the measurement gap in pharma training
Pharma leaders know training is a critical investment. Whether it’s onboarding new hires, preparing a field team for launch,…
From passive to performance: Our 4-step method to drive lasting behavior change
In pharma, knowing isn’t enough. Performance happens when knowledge turns into action and that’s where most training…
A smarter way to turn strategic priorities into measurable impact
In pharma, the stakes are high. Brand teams chase ambitious goals, while training teams are tasked with…
Why less is more in training: Maximizing ROI under budget constraints
In life sciences, learning and development leaders are navigating a new set of pressures. Teams are expected…
6 Common pitfalls of L&D in pharma and what to do instead
Creating learning programs in the life sciences space is high-stakes. Whether you’re supporting sales teams preparing for…
- « Previous
- 1
- 2
- 3
- Next »